Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.

ABSTRACT:

SUBMITTER: Gregg LP 

PROVIDER: S-EPMC11706553 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature